Using electric stimulation to improve memory in veterans with brain injuries

Treatment of Verbal Retrieval Deficits in Mild Traumatic Brain Injury With High Definition Transcranial Direct Current Stimulation

NA · The University of Texas at Dallas · NCT04869059

This study is testing if a special type of brain stimulation can help veterans with mild brain injuries improve their memory and thinking skills.

Quick facts

PhaseNA
Study typeInterventional
Enrollment136 (estimated)
Ages18 Years to 75 Years
SexAll
SponsorThe University of Texas at Dallas (other)
Locations1 site (Dallas, Texas)
Trial IDNCT04869059 on ClinicalTrials.gov

What this trial studies

This study tests the effectiveness of transcranial Direct Current Stimulation (tDCS) on the presupplementary motor area of the brain to enhance verbal retrieval in military veterans who have experienced mild traumatic brain injuries. Participants will be randomly assigned to receive either active tDCS or sham treatment over 15 sessions, with cognitive assessments conducted throughout the intervention and at follow-up. The study aims to evaluate not only the primary outcome of verbal retrieval but also other cognitive abilities and EEG measures, while examining how baseline cognitive assessments and concussion history may predict treatment responses.

Who should consider this trial

Good fit: Ideal candidates are veterans aged 18-75 with a history of mild to moderate traumatic brain injury leading to verbal retrieval deficits.

Not a fit: Patients with severe traumatic brain injuries or significant psychological or neurological disorders will not benefit from this study.

Why it matters

Potential benefit: If successful, this approach could significantly improve cognitive function and quality of life for veterans suffering from the effects of traumatic brain injuries.

How similar studies have performed: While the use of tDCS is gaining traction, this specific application for improving verbal retrieval in veterans with traumatic brain injuries is relatively novel and has not been extensively tested.

Eligibility criteria

Show full inclusion / exclusion criteria
Inclusion Criteria: Participants are to be between the ages of 18-75, have previously served in the US armed services, and have had a traumatic brain injury that has led to a verbal retrieval deficit based on neuropsychological testing criteria. Traumatic brain injury must be in the mild to moderate range based on evaluation, including, the Ohio State TBI Identification Method (administered by our research group). You must be fluent in speaking and reading English.

Exclusion Criteria: Exclusion criteria include a history of a psychological or neurological disorder, including, dementia of any type, epilepsy or other seizure disorders, severe traumatic brain injury, post-traumatic stress disorder, brain tumor, present drug abuse, stroke, blood vessel abnormalities in the brain, Parkinson's disease, Huntington's disease, or multiple sclerosis. Additionally, exclusion criteria include inability to give informed consent; cranial implants or skull defects that affect tDCS administration; and use of medications that interact with or potentially interact with tDCS effects, including, anti-convulsants, amphetamines, L-dopa, carbamazepine, sulpiride, pergolide, lorazepam, rivastigmine, dextromethorphan, D-cycloserine, flunarizine, ropinirole, or citalopram.

Where this trial is running

Dallas, Texas

Study contacts

How to participate

  1. Review the eligibility criteria above with your treating physician.
  2. Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
  3. Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.

View on ClinicalTrials.gov →

Conditions: Traumatic Brain Injury, Traumatic brain injury, transcranial direct current stimulation, electroencephalography, cognition, veteran traumatic brain injury

Last reviewed 2026-05-15 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.